Press "Enter" to skip to content

Annual Report of the Heyman Center for Ethics

Samuel and Ronnie Heyman Center for Ethics, Public Policy and the Professions

Center Report 2021


The Heyman Center focuses its teaching and research activities on ethical issues in public policy decisions. The Center sponsors symposia, speakers, and conferences, as well as supports the research, writing, and speaking engagements of its director.

Management and Reporting Line:

Joel L. Fleishman, Director of the Center, Professor of Law and Public Policy:  Performs research and writing in the areas of leadership, ethics, public service, philanthropy, and nonprofits; teaches a course listed in both the Sanford School and the Duke Law School entitled “The Idea of the Voluntary Society: Philanthropy, Public Policy, and Nonprofit Law and Management.”

Cassie Lewis, Administrative Assistant to the Director and Program Coordinator, Sr. Level for the Heyman Center:  Assists the Director with scheduling and travel as well as manages office administrative duties (including both Centers’ reports, budgets, grants oversight, event management), manages all staff in both the Heyman Center and the Center for Strategic Philanthropy & Civil Society (CSPCS) which includes internal HR duties for both centers.  (Effective 11/1/19)

Nicole Sweat, Staff Assistant:  Assists the Director and the Administrative Assistant with accounting, filing, correspondence, mass mailings, event arrangements, massive contact files updating, etc.  (Effective 11/1/19)

People Serviced:

MPP’s, MBA’s, M.Div’s, PPS undergrads, Law students (approx. 16) – enrolled in Professor Fleishman’s philanthropy and law course; practitioners and researchers in the areas of foundations, philanthropy and nonprofits; alumni, donors, parents, friends of the University, general public (Because Professor Fleishman’s office was once a major fundraising office for the University, many people look to the Heyman Center as one of their principal Duke connections.)

Budget Sources:

The proposed total operating budget for the Heyman Center for Fiscal Year ’22 (2021-2022), including salaries, is $772,890. The general operating funds (non-compensation) for the Heyman Center ($44,000 –much of which is allocated for travels related to the center and for events hosted by the director) are provided by an anonymous donor gift.  Salaries are covered as follows: Heyman Endowment (JLF), the Ketner Endowment (JLF), the Heyman main operating funds (Nicole/Cassie), Oak Quasi Endowment (JLF), the Duke President’s Office (JLF), and the Duke Provost’s Office (JLF). Also, Joel’s summer supplement salary payment (one payment at half rate due to Covid-19 cutbacks) in 2021 was paid out of JLF’s book royalties’ fund, through a payment from the Bloomberg Philanthropies for a research project completed by Joel Fleishman during the spring and completed in July 2021.



Major Activity Highlights – Previous (2020-2021) and Upcoming (2021-2022):

Executive Education Program on Corporate Social Responsibility

Joel Fleishman has recently helped Stan Litow, Sanford Adjunct Instructor, to recruit some of the corporate speakers, especially Robert K. Steel, Partner and CEO Perella Weinberg Partners, and Roseann Lynch, Executive Vice President and Chief People Officer of the Ralph Lauren Corporation, for the new Executive Education Program on Corporate Social Responsibility.


Philanthropy Course in Spring Semester

Professor Fleishman teaches a philanthropy course (which is cross-listed with the Law School), entitled “The Idea of the Voluntary Society: Philanthropy, Voluntarism, and Not-for-Profit Law and Management,” in the spring of each year.  In the spring of 2021, the Heyman Center hosted the following guest speakers for the class: Max Stier, CEO of Partnership for Public Service; John Rice, Founder and CEO of Management Leadership for Tomorrow; and Shena Ashley, Vice President, Nonprofits and Philanthropy, at the Urban Institute.



As previously recorded, work is still being completed on the initiatives that are being facilitated by the Heyman Center:

  1. The Ralph Lauren Corporation DIVERSITY AND INCLUSIVENESS training program for North Carolina employees in the fields of law enforcement, education, food and nutrition, and re-employment. The following outline prepared by Roseann Lynch, Chief People Officer of the Ralph Lauren Corporation, describes this initiative, all the training for which is delivered by full-time employees of the Ralph Lauren Corporation who work for the Ralph Lauren Corporation in North Carolina in its work on Diversity and Inclusiveness, and their time will be donated by the Ralph Lauren Corporation. The Office of Governor Roy Cooper and his Strategic Partnerships Director Jenni Owen are developing and overseeing the implementation of this program.
    1. State police—reviewing the recruitment, training, diversity, micro-aggression training, periodic psychological analysis, and transparency of records
    2. Education—teach the truth, working with the education curriculum to train the real historical events impacting the Native American and the Black and African-American people
    3. Nutrition and wellness, with Covid-19 impacting the Native American, Black, Brown, and African-American communities predominantly—how do we create opportunities for nutritional programs, and healthy food options to the underserved communities
    4. High numbers of unemployed—a re-employment strategy.

UPDATE: Joel Fleishman participates in approximately monthly meetings with the RL team to review its ongoing activities and provide advice. In that connection, he has introduced Sanford School Assistant Dean Spencer Darden to the RL NC team. He has also established contacts for the RL team with NC state government officials, and keeps Jenni Owen, Governor Cooper’s Assistant for Strategic Partnerships, posted on the RL activities.

  1. The second initiative that is being developed is called a Not-for-Profit Convergence Health Research Institute, the designer of which is Dr. Gary Eichenbaum, Vice President for Translational Science and Safety, Office of the Chief Medical Officer, Johnson & Johnson Corporation. The Sanford School Heyman Center is working with Dr. Eichenbaum pro bono to facilitate the development of this entity. Following is Dr. Eichenbaum’s outlines of the key parts of the initiative: “Overall concept: Establish a self-sustaining Not-for-Profit Convergence Health (Drug/Device/Health Data) Research Institute that is linked to a for-profit bio/health-tech incubator that both have a social mission related to creating mentoring and career opportunities in healthcare for people in underserved communities while at the same time creating transformation products that address unmet medical needs in those communities.

Sustainable Endowed Convergence Health (Drug/Device/Data) Research Institute Affiliated with One or More Research Hospitals Proximal to the Inner City

  • Research Mission (50%) –Institute that integrates Drug – Device and Real-World Data research to develop transformational solutions in the areas of Oncology, Regenerative Medicine and Infectious Disease with a focus on diseases that disproportionately impact minorities
  • Social Mission (50%) –Cultivate talent from the inner city by running programs in local middle/high schools, providing fellowships for undergraduates/graduates, and establishing connections to companies that commit to mentoring and providing opportunities for the young scientists and researchers that are engaged at the institute.
  • Proposed Funding – $X million – Not for Profit Funded with Philanthropic Donations
  • Corporate Partnerships/Sponsorship – At least 1 Large Global Pharma Company, 1-Large Device/Health Tech Company
  • Intellectual Property (IP) – Institute would license IP to Convergence Incubator (see below) and in exchange would get an equity stake in the Convergence health incubator

Convergence Health Innovation Incubator (For Profit)

  • Mission: Manage a portfolio of Convergence drug/device projects in Oncology, Regenerative Medicine and Infectious Disease that provide transformational solutions to patients
  • Leadership – TBD
  • Funding – VC and corporate backed funding
  • Scientific Anchor and IP – IP from Convergence Research Institute and licenses to 1-2 products that are clinical or commercial stage assets from pharma/biotech partners
  • Corporate Partnerships/Sponsorship – At least 1 Large Global Pharma Company, 1-Large Device/Health Tech Company
  • Proposed Funding: $X Million